Literature DB >> 18562523

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.

Berend Jan Bosch1, Willem Bartelink, Peter J M Rottier.   

Abstract

Unlike other class I viral fusion proteins, spike proteins on severe acute respiratory syndrome coronavirus virions are uncleaved. As we and others have demonstrated, infection by this virus depends on cathepsin proteases present in endosomal compartments of the target cell, suggesting that the spike protein acquires its fusion competence by cleavage during cell entry rather than during virion biogenesis. Here we demonstrate that cathepsin L indeed activates the membrane fusion function of the spike protein. Moreover, cleavage was mapped to the same region where, in coronaviruses carrying furin-activated spikes, the receptor binding subunit of the protein is separated from the membrane-anchored fusion subunit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562523      PMCID: PMC2519682          DOI: 10.1128/JVI.00415-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

Review 1.  Lysosomal cysteine proteases: more than scavengers.

Authors:  B Turk; D Turk; V Turk
Journal:  Biochim Biophys Acta       Date:  2000-03-07

2.  Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies.

Authors:  L J Calder; L González-Reyes; B García-Barreno; S A Wharton; J J Skehel; D C Wiley; J A Melero
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

Review 3.  Lysosomal cysteine proteases regulate antigen presentation.

Authors:  Karen Honey; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

4.  Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

Authors:  Shutoku Matsuyama; Makoto Ujike; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

5.  Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain.

Authors:  Fang Li; Marcelo Berardi; Wenhui Li; Michael Farzan; Philip R Dormitzer; Stephen C Harrison
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.

Authors:  Sarah A Connolly; George P Leser; Hsien-Shen Yin; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

7.  Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.

Authors:  Zhaozhu Qiu; Susan T Hingley; Graham Simmons; Christopher Yu; Jayasri Das Sarma; Paul Bates; Susan R Weiss
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

Authors:  Graham Simmons; Dhaval N Gosalia; Andrew J Rennekamp; Jacqueline D Reeves; Scott L Diamond; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

9.  Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion.

Authors:  Daniel R Beniac; Shauna L deVarennes; Anton Andonov; Runtao He; Tim F Booth
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

10.  Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.

Authors:  Kathryn E Follis; Joanne York; Jack H Nunberg
Journal:  Virology       Date:  2006-03-07       Impact factor: 3.616

View more
  134 in total

1.  Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

Authors:  Shutoku Matsuyama; Noriyo Nagata; Kazuya Shirato; Miyuki Kawase; Makoto Takeda; Fumihiro Taguchi
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins.

Authors:  Kathryn L Schornberg; Charles J Shoemaker; Derek Dube; Michelle Y Abshire; Sue E Delos; Amy H Bouton; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

3.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.

Authors:  Ana B Pavel; Jianni Wu; Yael Renert-Yuval; Ester Del Duca; Jacob W Glickman; Rachel L Miller; Amy S Paller; James G Krueger; Emma Guttman-Yassky
Journal:  Allergy       Date:  2020-08-24       Impact factor: 13.146

5.  Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Authors:  Oliver Wicht; Christine Burkard; Cornelis A M de Haan; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 6.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.

Authors:  Sandrine Belouzard; Ikenna Madu; Gary R Whittaker
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

8.  SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro.

Authors:  Susan F Dosch; Supriya D Mahajan; Arlene R Collins
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

Review 9.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

10.  Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.

Authors:  Yiu-Wing Kam; Yuushi Okumura; Hiroshi Kido; Lisa F P Ng; Roberto Bruzzone; Ralf Altmeyer
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.